Welcome MHBP members!
Available at no cost to you
It’s estimated that the number of new melanoma cases diagnosed in 2024 will increase by 7.3%¹
The number of melanoma deaths are expected to increase by 3.8% in 2024¹.
70 to 80% of melanomas arise on apparently normal skin.²
When detected early, the estimated five-year survival rate for melanoma patients is over 99%.3
Take images of your skin
If attending an in-person event, your Skinographer will take regional images of your skin and close-ups of any areas or spots you're concerned about.
If you're screening virtually, the SkinIO app will guide you through the photo-taking process. The app allows you to capture regional images of your skin, as well as as many close-ups as you want. You can take these images yourself using selfie mode, or with the help of a partner.
Submit images to be examined by a board-certified dermatologist
Your images are sent to our panel of dermatologists who analyze each image to determine if there are any areas of concern. Your images are uploaded to a HIPAA-compliant cloud server, never stored on a device.
Receive your results in 2-3 days
If the dermatologist recommends an in-person follow-up for further evaluation, our Connection to Care team will contact you. Our team can also help connect you with a local, in-network dermatologist who will see you in 2-3 weeks.
Marty, Melanoma Survivor
Robert, Melanoma Survivor
Kathy, SkinIO User
Your clinical-grade images are saved in your digital skin health record and safely stored on our HIPAA-compliant server. As more images are submitted over time (yearly at a minimum), the AI-technology gets smarter and can track changes in your skin, including identifying any new spots or subtle changes you may not notice!
Eligibility: Available to all MHBP Standard Option and Value Plan members, not available to Consumer Option members.
¹ Cancer Facts & Figures 2024. Accessed 3/5/2024, https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2024/2024-cancer-facts-and-figures-acs.pdf
² Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol 2011; 29(3):257-263.
3 Cymerman RM, Shao Y, Wang K, et al. De novo versus nevus-associated melanomas: Differences in associations with prognostic indicators and survival. J Natl Cancer Inst 2016 May 27; 108(10). doi:10.1093/jnci/djw121.